EAP management SaaS offers a centralized platform to oversee all aspects of the Expanded Access Program, including patient enrollment, treatment tracking, regulatory compliance, and data management. This centralization improves efficiency and ensures better control over the program

The system facilitates secure patient enrollment by verifying eligibility against predefined clinical criteria. This simplifies the process and ensures that only appropriate patients are enrolled in the program, ensuring patient safety and compliance with regulations.

The platform provides real-time tracking of patient data, including treatment outcomes and adverse events. This allows for faster decision-making and early detection of any safety or efficacy concerns, which can be critical in managing expanded access treatments.

The EAP SaaS ensures compliance with local, national, and international regulatory requirements by maintaining an audit trail, handling required documentation, and generating reports. This reduces the risk of regulatory breaches and helps ensure that all aspects of the program meet regulatory standards

The system facilitates communication between various stakeholders, including healthcare providers, pharmaceutical companies, and patients. It enables secure messaging, document sharing, and real-time updates on patient progress, improving collaboration and reducing communication bottlenecks.

With configurable workflows, the SaaS system automates critical tasks such as patient consent management, approval routing, and regulatory submission tracking. This reduces administrative burdens, increases program efficiency, and minimizes human error.

The platform allows for customizable access, ensuring that only authorized personnel can access sensitive patient information. Role-based permissions ensure secure handling of data, fostering trust among patients, healthcare providers, and regulatory bodies.

The system serves as a centralized repository for all program-related documents, including patient records, treatment protocols, regulatory submissions, and communication logs. This makes it easy to access and manage vital information at any stage of the program.

The SaaS solution is scalable, allowing pharmaceutical companies to manage multiple EAPs across different regions or therapeutic areas. It can handle an increasing number of patients and trials without compromising performance or functionality.

The SCIMAX IIT platform is scalable, adapting to the needs of both small-scale investigator-initiated studies and large, multi-center trials. The flexibility of the system allows it to be customized to fit various trial types and therapeutic areas

The platform offers 24×7 support, easy scalability, certified-ready Integrations, automatic updates, higher security, in-built data privacy controls, performance, reliability, flexible pricing and options etc.